These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1313398)

  • 1. Serum oncoproteins and growth factors in asbestosis and silicosis patients.
    Brandt-Rauf PW; Smith S; Hemminki K; Koskinen H; Vainio H; Niman H; Ford J
    Int J Cancer; 1992 Apr; 50(6):881-5. PubMed ID: 1313398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
    Xue C; Wu N; Li X; Qiu M; Du X; Ye Q
    BMC Pulm Med; 2017 Nov; 17(1):144. PubMed ID: 29149883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum oncoproteins in asbestosis patients.
    Partanen R; Koskinen H; Oksa P; Hemminki K; Carney W; Smith S; Brandt-Rauf P
    Clin Chem; 1995 Dec; 41(12 Pt 2):1844-7. PubMed ID: 7497643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emphysema in silica- and asbestos-exposed workers seeking compensation. A CT scan study.
    Bégin R; Filion R; Ostiguy G
    Chest; 1995 Sep; 108(3):647-55. PubMed ID: 7656611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor-alpha (TNF-alpha) in patients who have asbestosis and develop cancer.
    Partanen R; Koskinen H; Hemminki K
    Occup Environ Med; 1995 May; 52(5):316-9. PubMed ID: 7795753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma.
    Yasumitsu A; Tabata C; Tabata R; Hirayama N; Murakami A; Yamada S; Terada T; Iida S; Tamura K; Fukuoka K; Kuribayashi K; Nakano T
    J Thorac Oncol; 2010 Apr; 5(4):479-83. PubMed ID: 20357617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels.
    Pass HI; Lott D; Lonardo F; Harbut M; Liu Z; Tang N; Carbone M; Webb C; Wali A
    N Engl J Med; 2005 Oct; 353(15):1564-73. PubMed ID: 16221779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of increased amounts of the extracellular domain of the c-erbB-2 oncoprotein in serum during pulmonary carcinogenesis in humans.
    Brandt-Rauf PW; Luo JC; Carney WP; Smith S; De Vivo I; Milling C; Hemminki K; Koskinen H; Vainio H; Neugut AI
    Int J Cancer; 1994 Feb; 56(3):383-6. PubMed ID: 7906254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum growth factors in asbestosis patients.
    Li Y; Karjalainen A; Koskinen H; Vainio H; Pukkala E; Hemminki K; Brandt-Rauf PW
    Biomarkers; 2009 Feb; 14(1):61-6. PubMed ID: 19283526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients.
    Partanen R; Hemminki K; Koskinen H; Luo JC; Carney WP; Brandt-Rauf PW
    J Occup Med; 1994 Dec; 36(12):1324-8. PubMed ID: 7884573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms in the pathogenesis of asbestosis and silicosis.
    Mossman BT; Churg A
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1666-80. PubMed ID: 9603153
    [No Abstract]   [Full Text] [Related]  

  • 12. TruCutR needle biopsy in asbestosis and silicosis: correlation of histological changes with radiographic changes and pulmonary function in 41 patients.
    Tukiainen P; Taskinen E; Korhola O; Valle M
    Br J Ind Med; 1978 Nov; 35(4):292-304. PubMed ID: 737136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of growth-factor receptors, egfr and Neu in asbestosis patients - a follow-up-study.
    Partanen R; Hemminki K; Brandtrauf P; Jin C; Koskinen H
    Int J Oncol; 1994 May; 4(5):1025-8. PubMed ID: 21567014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The additional risk of malignant mesothelioma in former workers and residents of Wittenoom with benign pleural disease or asbestosis.
    Reid A; de Klerk N; Ambrosini G; Olsen N; Pang SC; Musk AW
    Occup Environ Med; 2005 Oct; 62(10):665-9. PubMed ID: 16169910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study.
    Cvitanović S; Znaor L; Konsa T; Ivancević Z; Perić I; Erceg M; Vujović M; Vuković J; Beg-Zec Z
    Croat Med J; 2003 Oct; 44(5):618-25. PubMed ID: 14515425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed pneumoconiosis: silicosis, asbestosis, talcosis, and berylliosis.
    Mark GJ; Monroe CB; Kazemi H
    Chest; 1979 Jun; 75(6):726-8. PubMed ID: 436529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention of asbestos fibres in lungs of workers with asbestosis, asbestosis and lung cancer, and mesothelioma in Asbestos township.
    Dufresne A; Bégin R; Massé S; Dufresne CM; Loosereewanich P; Perrault G
    Occup Environ Med; 1996 Dec; 53(12):801-7. PubMed ID: 8994398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient with asbestos-induced lung cancer complicated by silicosis.
    Kishimoto T; Tsuda K
    Ind Health; 2001 Apr; 39(2):189-93. PubMed ID: 11341551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dust exposure and mortality in an American chrysotile asbestos friction products plant.
    McDonald AD; Fry JS; Woolley AJ; McDonald JC
    Br J Ind Med; 1984 May; 41(2):151-7. PubMed ID: 6326794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Respiratory malignancies induced by asbestos exposure and evaluation of cases with typical pleural malignant mesothelioma and lung cancer with asbestosis].
    Kishimoto T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Aug; 28(8):1078-84. PubMed ID: 2243458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.